Health Trials

Systemic Lupus Erythematosus(SLE)

1

Review clinical trials related to Systemic Lupus Erythematosus(SLE). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

This is a single arm, open-label, dose escalation and expansion study to evaluate the safety, tolerability and preliminary efficacy of autologous chimeric antigen receptor T (CAR-T) cells targeting CD19/CD22/BCMA(BZE2204) in patients with relapsed or refractory active autoimmune diseases, including idiopathic inflammatory myopathies(IIM), immune thrombocytopenia(ITP), systemic lupus erythematosus(SLE).

Participants needed: 20
Trial details
Phase: Early Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Cell Therapy Group Co.,LtdUpdated: Sep 16, 2025Locations: 1
Eligibility criteria

Males or females, aged 18-70 years old [+26]

A history of severe hypersensitivity or allergic reactions, or contraindications... [+18]

Read more